Our Research Methodology
We began by mapping the product catalog and pricing. Willow presents a simple structure: compounded semaglutide at $299 per month across injections, sublingual tablets, and drops; compounded tirzepatide starting at $399 per month with injection and oral options; and a separate GLP‑90 program built around daily sublingual tablets at $399 per month for three months. Monthly prices include the prescription, medication, and shipping, and the company positions same‑day prescribing with free two‑day shipping when in stock.
Next, we reviewed the fine print. The Terms and Informed Consent frame Willow Health Services as a technology platform that connects patients with affiliated physicians and pharmacies, rather than a medical provider or pharmacy itself. The Privacy Policy notes that the service may be used only within certain U.S. states. The FAQ clarifies that Willow dispenses compounded formulations prepared by licensed compounding pharmacies and that these products are not FDA‑approved and have not been evaluated for therapeutic equivalence to branded drugs. Terms and Conditions.
We then audited the experience promises. Willow emphasizes same‑day approval, two‑day shipping, and unlimited messaging; in the FAQ, the company states support messages are generally answered within 24 hours. The refund policy offers full refunds for cancellations made before a prescription is submitted to the pharmacy; after that point, orders are typically non‑refundable because medications are custom compounded. These policies outline what patients should expect operationally.
Finally, we triangulated service‑quality signals from public reviews and community discussions to identify recurring patterns. We saw consistent praise for quick approvals and clear pricing, alongside intermittent complaints about delayed shipments and difficulty reaching support for time‑sensitive issues. We also noted occasional confusion about state eligibility and whether top tirzepatide concentrations cost more than the base plan. While Willow highlights testing of compounded lots, it does not disclose whether partner pharmacies are 503A or 503B facilities. Trustpilot.
In sum, our review found Willow to be a pragmatic, budget‑focused GLP‑1 option for patients who prioritize affordability, speed, and telehealth convenience over premium support and brand‑name medications. Strengths include flat pricing, multiple formulations, and rapid fulfillment; constraints include the limitations of compounded care and state availability. Patients who want in‑person access, need insurance billing, or prefer branded drugs may be better served elsewhere, whereas those who value simple subscription pricing and fast starts will likely find Willow a strong fit.
- Flat monthly pricing includes prescription, medication, and shipping.
- Same‑day prescribing and free two‑day shipping when in stock.
- Compounded medications only; not FDA‑approved brands.







